The use of bioprostheses for heart valve therapy has gradually evolved over several
decades and both surgical and transcatheter devices are now highly successful. The rapid …

Valvular heart disease (VHD) has become a burden and a growing public health problem in
humans, causing significant morbidity and mortality worldwide. An increasing number of …

Materials currently used to repair or replace a heart valve are not durable. Their limited
durability related to structural degeneration or thrombus formation is attributed to their …

Cardioaortic embolism to the brain accounts for approximately 15–30% of ischaemic strokes
and is often referred to as 'cardioembolic stroke'. One-quarter of patients have more than …

Glutaraldehyde crosslinked biological heart valves (BHVs) are increasingly implanted with
development of transcatheter heart valve implantation. While poor cytocompatibility and …

Heart valve replacement is an effective therapy for patients with moderate to severe valvular
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …

In the last decade, the number of transcatheter heart valve replacement for severe heart
valve disease has increased exponentially. Although the bioprosthetic artificial heart valve …

Background The ideal prosthesis for tricuspid valve replacement (TVR) continues to be
debated. There are few published data comparing mechanical and bioprosthetic valves, and …

Cardiogenic shock (CS) is a complex multifactorial clinical syndrome, developing as a
continuum, and progressing from the initial insult (underlying cause) to the subsequent …

The AngioVac System has already proved to be effective and safe in the treatment of
thrombotic and endocarditic formations concerning the venous district and the tricuspid …